| Louise G Ligresti, MD | |
|
1 Valley Health Plz, Paramus, NJ 07652-3628 | |
| (201) 634-5353 | |
| (201) 634-5343 |
| Full Name | Louise G Ligresti |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine - Hematology & Oncology |
| Location | 1 Valley Health Plz, Paramus, New Jersey |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215960232 | NPI | - | NPPES |
| 7294701 | Medicaid | NJ | |
| 830004825 | Other | NJ | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 25MA06569700 (New Jersey) | Primary |
| Entity Name | Rutgers Health-rwj Scleroderma Program |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679655781 PECOS PAC ID: 5193764991 Enrollment ID: O20050502000326 |
News Archive
Spectrum Pharmaceuticals, Inc. (NasdaqGM:SPPI), a commercial-stage biotechnology company with a focus in oncology, today announced that it has received commitments from institutional investors to purchase $50 million of securities in a registered direct offering.
Sen. Hillary Rodham Clinton (D-N.Y.), who is running for the Democratic presidential nomination, recently signed a pledge to commit to investing $50 billion by 2013 to fight HIV/AIDS domestically and worldwide, the New York Times reports. Clinton also plans to issue a formal policy on the disease, according to the Times (Seelye, "The Caucus," New York Times, 10/26).
The United States Census Bureau estimates that by 2060, nearly one in four Americans will be age 65 and older. As America turns increasingly gray, numerous stressors, such as declining health, loss of loved ones or independence, negatively impact the lives of older adults.
Genesis Biopharma, Inc., a biotechnology company developing targeted cancer immunotherapies, today announced it has signed a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute.
› Verified 3 days ago
| Entity Name | Memorial Sloan Kettering Cancer Center At Basking Ridge New Jersey |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184637886 PECOS PAC ID: 0143229534 Enrollment ID: O20061213000044 |
News Archive
Spectrum Pharmaceuticals, Inc. (NasdaqGM:SPPI), a commercial-stage biotechnology company with a focus in oncology, today announced that it has received commitments from institutional investors to purchase $50 million of securities in a registered direct offering.
Sen. Hillary Rodham Clinton (D-N.Y.), who is running for the Democratic presidential nomination, recently signed a pledge to commit to investing $50 billion by 2013 to fight HIV/AIDS domestically and worldwide, the New York Times reports. Clinton also plans to issue a formal policy on the disease, according to the Times (Seelye, "The Caucus," New York Times, 10/26).
The United States Census Bureau estimates that by 2060, nearly one in four Americans will be age 65 and older. As America turns increasingly gray, numerous stressors, such as declining health, loss of loved ones or independence, negatively impact the lives of older adults.
Genesis Biopharma, Inc., a biotechnology company developing targeted cancer immunotherapies, today announced it has signed a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute.
› Verified 3 days ago
| Entity Name | Barnabas Health Medical Group Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841557246 PECOS PAC ID: 9537316955 Enrollment ID: O20120820000951 |
News Archive
Spectrum Pharmaceuticals, Inc. (NasdaqGM:SPPI), a commercial-stage biotechnology company with a focus in oncology, today announced that it has received commitments from institutional investors to purchase $50 million of securities in a registered direct offering.
Sen. Hillary Rodham Clinton (D-N.Y.), who is running for the Democratic presidential nomination, recently signed a pledge to commit to investing $50 billion by 2013 to fight HIV/AIDS domestically and worldwide, the New York Times reports. Clinton also plans to issue a formal policy on the disease, according to the Times (Seelye, "The Caucus," New York Times, 10/26).
The United States Census Bureau estimates that by 2060, nearly one in four Americans will be age 65 and older. As America turns increasingly gray, numerous stressors, such as declining health, loss of loved ones or independence, negatively impact the lives of older adults.
Genesis Biopharma, Inc., a biotechnology company developing targeted cancer immunotherapies, today announced it has signed a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute.
› Verified 3 days ago
| Entity Name | Msk Bergen |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558814657 PECOS PAC ID: 1456614114 Enrollment ID: O20180410002157 |
News Archive
Spectrum Pharmaceuticals, Inc. (NasdaqGM:SPPI), a commercial-stage biotechnology company with a focus in oncology, today announced that it has received commitments from institutional investors to purchase $50 million of securities in a registered direct offering.
Sen. Hillary Rodham Clinton (D-N.Y.), who is running for the Democratic presidential nomination, recently signed a pledge to commit to investing $50 billion by 2013 to fight HIV/AIDS domestically and worldwide, the New York Times reports. Clinton also plans to issue a formal policy on the disease, according to the Times (Seelye, "The Caucus," New York Times, 10/26).
The United States Census Bureau estimates that by 2060, nearly one in four Americans will be age 65 and older. As America turns increasingly gray, numerous stressors, such as declining health, loss of loved ones or independence, negatively impact the lives of older adults.
Genesis Biopharma, Inc., a biotechnology company developing targeted cancer immunotherapies, today announced it has signed a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Louise G Ligresti, MD 1 Valley Health Plz, Paramus, NJ 07652-3628 Ph: (201) 634-5353 | Louise G Ligresti, MD 1 Valley Health Plz, Paramus, NJ 07652-3628 Ph: (201) 634-5353 |
News Archive
Spectrum Pharmaceuticals, Inc. (NasdaqGM:SPPI), a commercial-stage biotechnology company with a focus in oncology, today announced that it has received commitments from institutional investors to purchase $50 million of securities in a registered direct offering.
Sen. Hillary Rodham Clinton (D-N.Y.), who is running for the Democratic presidential nomination, recently signed a pledge to commit to investing $50 billion by 2013 to fight HIV/AIDS domestically and worldwide, the New York Times reports. Clinton also plans to issue a formal policy on the disease, according to the Times (Seelye, "The Caucus," New York Times, 10/26).
The United States Census Bureau estimates that by 2060, nearly one in four Americans will be age 65 and older. As America turns increasingly gray, numerous stressors, such as declining health, loss of loved ones or independence, negatively impact the lives of older adults.
Genesis Biopharma, Inc., a biotechnology company developing targeted cancer immunotherapies, today announced it has signed a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute.
› Verified 3 days ago
Dr. Salvatore Focella, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1 W Ridgewood Ave, Paramus, NJ 07652 Phone: 201-444-5807 Fax: 201-447-9338 | |
Dr. Michael Nevins, MD Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 230 East Ridgewood Ave, Paramus, NJ 07652 Phone: 201-967-4156 | |
Dr. Howard Weizman, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1 Kalisa Way, Suite 210, Paramus, NJ 07652 Phone: 201-447-0013 Fax: 201-255-4515 | |
Thomas Andrew Cacciola, MD Hematology & Oncology Medicare: May Accept Medicare Assignments Practice Location: 403 Farview Ave, Paramus, NJ 07652 Phone: 201-261-8386 Fax: 201-261-8827 | |
Dr. Theodore P Sgambati, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2 Sears Dr, Floor 2, Paramus, NJ 07652 Phone: 201-262-2333 Fax: 201-262-4515 | |
Ranjan Ginde, D.O. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 650 From Rd Fl 5, Paramus, NJ 07652 Phone: 201-639-6630 | |
Elaine Zhai, D.O. Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 30 West Century Road, Suite 210, Paramus, NJ 07652 Phone: 201-833-3000 |